The PhD Program in Biomedical Sciences (PPBS) conducted its third annual white coat ceremony to recognize 19 students from the Class of 2018-2019 — 14 doctoral students and five MD-PhD students — who completed their first year in the program and are moving on to their research laboratory match.
Medical student Esha Chebolu has been selected to participate in a yearlong residential program that trains the next generation of clinician-scientists and biomedical researchers on the National Institutes of Health (NIH) campus in Bethesda, Maryland.
Jessy J. Alexander, PhD, research professor of medicine in the Division of Nephrology, will use her 2019-20 Fulbright scholarship to study how the microbiome — the collective microorganisms that live on and in the human body — may impact people in India diagnosed with lupus.
Oscar G. Gomez, MD, PhD, associate professor of pediatrics and chief of the Division of Infectious Diseases, has been named to the second class of fellows at the SUNY Hispanic Leadership Institute (HLI).
Stephanie Anzman-Frasca, assistant professor of pediatrics in the Division of Behavioral Medicine, has been at the forefront of research on trying to help children and adults make healthier food choices.
Andrew H. Talal, MD — who pioneered the use of telemedicine to treat patients with hepatitis C virus (HCV) in opioid treatment programs — has shared the successes of this approach with the National Academy of Medicine (NAM).
Nine faculty members with a variety of clinical and research experience — representing five medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
A select group of Western New York high school students learned surgical skills this spring under the guidance of surgeons doing their residency training at the Jacobs School of Medicine and Biomedical Sciences.
Graduate Medical Education Awards of Excellence for 2019 have been presented to the physician who directs the child and adolescent psychiatry fellowship program and the administrator of the general surgery residency program.
The results of a long-term study led by Steven E. Lipshultz, MD, A. Conger Goodyear Professor and Chair of the Department of Pediatrics, could allay many concerns about the possibility drugs for attention deficit hyperactivity disorder (ADHD) could damage patients’ hearts.